Akums Drugs and Pharmaceuticals544222Pharmaceuticals, CDMO
Akums Drugs reported strong revenue and CDMO growth
By ScoutQuest · · 1 min read
- Revenue growth
- 32 percent
- Margins
- 14.5 percent
- CDMO revenue growth
- 38.6 percent
Heard on business television between 08:25:25 - 08:28:25 IST.
- Revenue up around 32%
- Margins around 14.5%
- CDMO revenue up around 38.6% year-on-year
- Analyst expects stock to be in the green today
Watch at source
behind live
- 1Open on YouTube
- 2Drag the seek bar left
- 3Watch this moment
Also from Akums Drugs and Pharmaceuticals
Akums Drugs files audio recording of Q2/H1 FY27 earnings conference call held November 3, 2026
3 Nov 2026
Final monitoring agency report: IPO proceeds of Rs 6,800.00 million fully utilised, no deviation
3 Nov 2026
Akums Q2 FY27: revenue up 31.9% to Rs 1,342 cr, PAT up 168.3% to Rs 115 cr
2 Nov 2026
Source: Live TV News Channel · 3 Nov 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.